New York Life Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

New York Life Investment Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,514	Closed	-$338K	–	1480
2023 Q4	$338K	Sell	5,514 -170	-3%	-$10.1K	﹤0.01%	1143
2023 Q3	$325K	Sell	5,684 -896	-14%	-$54.2K	﹤0.01%	1075
2023 Q2	$391K	Sell	6,580 -1,103	-14%	-$66K	﹤0.01%	1036
2023 Q1	$481K	Sell	7,683 -3,032	-28%	-$189K	0.01%	875
2022 Q4	$671K	Buy	10,715 +1,208	+13%	+$69.3K	0.01%	704
2022 Q3	$474K	Buy	9,507 +698	+8%	+$38.6K	0.01%	788
2022 Q2	$518K	Buy	+8,809	New	+$486K	0.01%	708

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York Life Investment Management's PBH Position: Q1 2024 in Review

New York Life Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2024, closing a stake of 5,514 shares — an estimated $338K sold.

New York Life Investment Management first reported a position in PBH in Q2 2022 and held it in 7 quarters. The position peaked at $671K in Q4 2022. 312 funds tracked by Wall St. Rank hold PBH as of Q1 2024.

New York Life Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2024 after selling out during the quarter.
New York Life Investment Management sold 5,514 Prestige Consumer Healthcare shares in Q1 2024, an estimated $338K.
New York Life Investment Management first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 7 quarters.
New York Life Investment Management's Prestige Consumer Healthcare position peaked at $671K in Q4 2022.
312 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.